What Researchers Did
Researchers retrospectively analyzed treatment strategies and outcomes in 35 male patients diagnosed with Fournier's gangrene between 2016 and 2021.
What They Found
Of 35 male patients, 13 (37%) received hyperbaric oxygen therapy (HBOT) combined with negative-pressure wound therapy (NPWT), while 22 (63%) received standard wound care. No fatalities occurred in the HBOT/NPWT group, compared to four deaths (18%) in the standard care group, though hospitalization was longer (mean 26 vs 23 days) and median resection extent was higher (3 vs 2) in the HBOT/NPWT group.
What This Means for Canadian Patients
For Canadian patients with Fournier's gangrene, combining hyperbaric oxygen therapy with negative-pressure wound therapy may offer a significant survival benefit. This approach could be considered as part of a comprehensive treatment strategy, potentially reducing mortality despite a slightly longer hospital stay.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The retrospective design and small sample size of 35 patients limit the generalizability of these findings.